Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,601
Closed -$430K 617
2025
Q1
$430K Buy
3,601
+416
+13% +$51.6K 0.03% 407
2024
Q4
$370K Sell
3,185
-12
-0.4% -$1.52K 0.02% 397
2024
Q3
$432K Sell
3,197
-195
-6% -$26.1K 0.03% 373
2024
Q2
$460K Sell
3,392
-142
-4% -$19.3K 0.03% 333
2024
Q1
$457K Sell
3,534
-15
-0.4% -$1.81K 0.04% 338
2023
Q4
$406K Buy
3,549
+34
+1% +$3.39K 0.03% 349
2023
Q3
$320K Buy
3,515
+1,236
+54% +$127K 0.03% 383
2023
Q2
$257K Buy
+2,279
New +$241K 0.03% 383
2020
Q3
Sell
-289
Closed -$19K 1089
2020
Q2
$19K Buy
289
+22
+8% +$1.45K 0.01% 551
2020
Q1
$17K Buy
267
+5
+2% +$394 0.01% 513
2019
Q4
$21K Buy
+262
New +$20.4K 0.01% 489

Other funds holding XYL

Procyon Advisors's XYL Position: Q2 2025 in Review

Procyon Advisors sold out of Xylem (XYL) in Q2 2025, closing a stake of 3,601 shares — an estimated $430K sold.

Procyon Advisors first reported a position in XYL in Q4 2019 and held it in 11 quarters. The position peaked at $460K in Q2 2024. 1,063 funds tracked by Wall St. Rank hold XYL as of Q2 2025.

  • Procyon Advisors reported no remaining Xylem position as of Q2 2025 after selling out during the quarter.
  • Procyon Advisors sold 3,601 Xylem shares in Q2 2025, an estimated $430K.
  • Procyon Advisors first reported a position in Xylem in Q4 2019 and held it in 11 quarters.
  • Procyon Advisors's Xylem position peaked at $460K in Q2 2024.
  • 1,063 funds tracked by Wall St. Rank held Xylem as of Q2 2025.

Based on Procyon Advisors's 13F filing for Q2 2025, filed 9 Jul 2025.